152 related articles for article (PubMed ID: 16182133)
1. Role of raf proteins in cardiac hypertrophy and cardiomyocyte survival.
Muslin AJ
Trends Cardiovasc Med; 2005 Aug; 15(6):225-9. PubMed ID: 16182133
[TBL] [Abstract][Full Text] [Related]
2. RAF protein-serine/threonine kinases: structure and regulation.
Roskoski R
Biochem Biophys Res Commun; 2010 Aug; 399(3):313-7. PubMed ID: 20674547
[TBL] [Abstract][Full Text] [Related]
3. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
4. Biochemistry. KSR plays CRAF-ty.
Shi F; Lemmon MA
Science; 2011 May; 332(6033):1043-4. PubMed ID: 21617065
[No Abstract] [Full Text] [Related]
5. Raf: a strategic target for therapeutic development against cancer.
Beeram M; Patnaik A; Rowinsky EK
J Clin Oncol; 2005 Sep; 23(27):6771-90. PubMed ID: 16170185
[TBL] [Abstract][Full Text] [Related]
6. Second nature: biological functions of the Raf-1 "kinase".
Baccarini M
FEBS Lett; 2005 Jun; 579(15):3271-7. PubMed ID: 15943972
[TBL] [Abstract][Full Text] [Related]
7. B-Raf and C-Raf signaling investigated in a simplified model of the mitogenic kinase cascade.
Robubi A; Mueller T; Fueller J; Hekman M; Rapp UR; Dandekar T
Biol Chem; 2005 Nov; 386(11):1165-71. PubMed ID: 16307482
[TBL] [Abstract][Full Text] [Related]
8. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
Lee M
Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
Roberts PJ; Der CJ
Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
[TBL] [Abstract][Full Text] [Related]
10. Identification of key residues in the A-Raf kinase important for phosphoinositide lipid binding specificity.
Johnson LM; James KM; Chamberlain MD; Anderson DH
Biochemistry; 2005 Mar; 44(9):3432-40. PubMed ID: 15736953
[TBL] [Abstract][Full Text] [Related]
11. Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1.
Kogut MH; Genovese KJ; He H
Mol Immunol; 2007 Mar; 44(7):1729-36. PubMed ID: 17045653
[TBL] [Abstract][Full Text] [Related]
12. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
13. A-Raf and Raf-1 work together to influence transient ERK phosphorylation and Gl/S cell cycle progression.
Mercer K; Giblett S; Oakden A; Brown J; Marais R; Pritchard C
Oncogene; 2005 Aug; 24(33):5207-17. PubMed ID: 15856007
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature.
Adnane L; Trail PA; Taylor I; Wilhelm SM
Methods Enzymol; 2006; 407():597-612. PubMed ID: 16757355
[TBL] [Abstract][Full Text] [Related]
15. Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling.
Klein M; Schermuly RT; Ellinghaus P; Milting H; Riedl B; Nikolova S; Pullamsetti SS; Weissmann N; Dony E; Savai R; Ghofrani HA; Grimminger F; Busch AE; Schäfer S
Circulation; 2008 Nov; 118(20):2081-90. PubMed ID: 18955668
[TBL] [Abstract][Full Text] [Related]
16. NBS1 is required for IGF-1 induced cellular proliferation through the Ras/Raf/MEK/ERK cascade.
Hematulin A; Sagan D; Eckardt-Schupp F; Moertl S
Cell Signal; 2008 Dec; 20(12):2276-85. PubMed ID: 18793719
[TBL] [Abstract][Full Text] [Related]
17. The subcellular localization of MEK and ERK--a novel nuclear translocation signal (NTS) paves a way to the nucleus.
Zehorai E; Yao Z; Plotnikov A; Seger R
Mol Cell Endocrinol; 2010 Jan; 314(2):213-20. PubMed ID: 19406201
[TBL] [Abstract][Full Text] [Related]
18. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate.
Santos SD; Verveer PJ; Bastiaens PI
Nat Cell Biol; 2007 Mar; 9(3):324-30. PubMed ID: 17310240
[TBL] [Abstract][Full Text] [Related]
19. Interaction between the protein kinase B-Raf and the alpha-subunit of the 11S proteasome regulator.
Kalmes A; Hagemann C; Weber CK; Wixler L; Schuster T; Rapp UR
Cancer Res; 1998 Jul; 58(14):2986-90. PubMed ID: 9679960
[TBL] [Abstract][Full Text] [Related]
20. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
